Pharmacotherapy for Schizophrenic Drug Users - 6

Yale University

Status and phase: Completed; Phase 2

Conditions: Shcizophrenia; Substance-Related Disorders; Cocaine-Related Disorders

Treatments: Behavioral: Amantadine

Study type: Interventional

Funder types: Other; Other U.S. Federal agency; NIH

Identifiers

NCT00000281

NIDA-09250-6

P50DA009250 (U.S. NIH Grant/Contract)

P50-09250-6

Details and patient eligibility

About

The purpose of this study is to evaluate maintenance neuroleptics for Schizophrenic patients who are cocaine abusers.

Sex: All

Ages: 18 to 55 years old

Volunteers: No Healthy Volunteers

Inclusion and exclusion criteria

Please contact site for information.